Acelrx Pharmaceuticals (ACRX)

Acelrx (ACRX) Financial Statements


Acelrx Financial Overview

Acelrx's market cap is currently ―. The company's EPS TTM is $6.229; its P/E ratio is 0.12; Acelrx is scheduled to report earnings on March 30, 2023, and the estimated EPS forecast is $-10.20. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 507.00K$ 570.00K$ 442.00K$ 2.00K$ 1.86M
Gross Profit$ -62.00K$ -306.00K$ -342.00K$ -1.23M$ 1.42M
EBIT$ -6.49M$ 70.99M$ -8.28M$ -7.45M$ -7.84M
EBITDA$ -6.07M$ 71.45M$ -7.86M$ -6.99M$ -7.35M
Net Income Common Stockholders$ -6.94M$ 70.66M$ -8.67M$ -7.92M$ -8.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.93M$ 22.92M$ 39.35M$ 51.63M$ 48.70M
Total Assets$ 48.31M$ 56.13M$ 71.97M$ 77.89M$ 72.26M
Total Debt$ 12.47M$ 14.39M$ 16.62M$ 18.62M$ 20.40M
Net Debt$ -3.45M$ -8.54M$ -22.73M$ -33.01M$ -28.30M
Total Liabilities$ 20.77M$ 22.99M$ 110.24M$ 113.79M$ 115.28M
Stockholders Equity$ 27.54M$ 33.14M$ -38.27M$ -35.89M$ -43.02M
Cash Flow-
Free Cash Flow$ -5.40M$ -8.81M$ -9.02M$ -8.03M$ -4.13M
Operating Cash Flow$ -5.24M$ -8.75M$ -8.93M$ -8.00M$ -3.94M
Investing Cash Flow$ 4.44M$ 9.17M$ 20.18M$ -4.44M$ -6.65M
Financing Cash Flow$ -1.64M$ -2.08M$ -2.08M$ 11.84M$ -2.46M
Currency in USD

Acelrx Earnings and Revenue History

Acelrx Debt to Assets

Acelrx Cash Flow

Acelrx Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis